DUVAC Trademark

Trademark Overview

On Thursday, August 20, 2020, a trademark application was filed for DUVAC with the United States Patent and Trademark Office. The USPTO has given the DUVAC trademark a serial number of 90126272. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 12, 2024. This trademark is owned by Orgenesis Inc.. The DUVAC trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic drugs and vaccines for the treatment of cancer
duvac

General Information

Serial Number90126272
Word MarkDUVAC
Filing DateThursday, August 20, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2020

Trademark Statements

Goods and ServicesTherapeutic drugs and vaccines for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrgenesis Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876
Party NameOrgenesis Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Trademark Events

Event DateEvent Description
Monday, February 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 12, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 21, 2023SOU EXTENSION 5 GRANTED
Tuesday, June 13, 2023SOU EXTENSION 5 FILED
Tuesday, June 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2023SOU EXTENSION 4 GRANTED
Tuesday, January 10, 2023SOU EXTENSION 4 FILED
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Saturday, July 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2022SOU EXTENSION 3 GRANTED
Thursday, July 7, 2022SOU EXTENSION 3 FILED
Thursday, July 7, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 3, 2022SOU EXTENSION 2 GRANTED
Monday, January 3, 2022SOU EXTENSION 2 FILED
Monday, January 3, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 1 GRANTED
Monday, June 14, 2021SOU EXTENSION 1 FILED
Monday, June 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 17, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 28, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 14, 2020ASSIGNED TO EXAMINER
Tuesday, September 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 24, 2020NEW APPLICATION ENTERED

Related Keywords

duvac cancer treatment vaccines drugs therapeutic